Longsee - English

Welcome to AACCDI

Health Committee of AACCDI
————————————————————

Associated  Manufacturers

Guangdong Longsee Biomedical Co., Ltd. 

Longsee Biomedical

is a company dedicated to "Clinical Intestinal Microecology, Medicine and Health Management", with data and basic technologies for the development and production of high-tech products. Industrial distribution in five areas:


IVD (reagents + equipment), In vitro diagnostic medical device, a medical procedure performed to detect, diagnose or monitor diseases, pathological processes, susceptibility or to determine a course of treatment. Medical tests such as physical and visual examinations, diagnostic imaging, genetic testing, chemical and cell analysis, related to clinical chemistry and molecular diagnostics, are typically performed in a medical setting.


Functional foods (in specialized literature it is usually abbreviated as FA) are those foods that are made not only for their nutritional characteristics but also to fulfill a specific function such as improving health and reducing the risk of contracting diseases. For this, biologically active components are added, such as minerals, vitamins, fatty acids, dietary fiber or antioxidants such as polyphenols contained in maqui, in El Calafate and in acai. This operation of adding exogenous nutrients is also called fortification. This type of food is an emerging field of food science that sees a very broad possibility of food research. Among the most mentioned achievements in the scientific literature and in the marketing of food products is the improvement of gastrointestinal functions, the contribution of redox and antioxidant systems, as well as the modification of the metabolism of macronutrients.


The fecal microbiota transplant or fecal transplant (FMT Fecal Microbiota Transplant) is the process by which gut microbes are transferred from the feces of a healthy individual to the large intestine of a sick person. It is done to restore the microflora of the colon by introducing a "healthy" bacterial flora through infusion of stool, for example, by colonoscopy, enema, orogastric tube, or orally in the form of a capsule containing material. lyophilized, obtained from a healthy donor. The efficacy of FMT has been demonstrated in clinical trials for the treatment of Clostridioides difficile infection (CDI), which can cause anything from diarrhea to pseudomembranous colitis. It can also help fight many other diseases, even allergies.


Living medicine is a type of biological that consists of a living organism that is used to treat a disease. This generally takes the form of a cell (animal, bacterial, or fungal) or a virus that has been genetically modified to possess therapeutic properties that is injected into a patient. Perhaps the oldest use of a living medicine is the use of leeches for bleeding, although living medicines have come a long way since then.


Medical treatment and nursing service. Care management is aimed at achieving the objective sought by nursing practice, this management as a process uses creativity, inquiry and transformation in this sense is considered heuristic.


Planning

Longsee Biomedical , uses microecological data as an entry point to promote the development of the intestinal flora transplant industry.


He has independently developed a national leading level of microflora transplantation for recipients and has a number of patents and copyrights for independently developed software.


Invest in high-throughput sequencing platform, human microecological life cycle database, multi-omic joint scientific research and detection, pathogenic microorganism detection, microecological detection of the female reproductive tract, personalized tumor drug evaluation, detection services and immunity evaluation, etc., to be constructed.


To ensure high-quality services, customers can fully enjoy a new green and healthy lifestyle and more intuitive human health data management.



Special in Time + Sensitivity


AACCDI and LONGSEE together created an identification system for COVID-19 & 50 types of viruses more ...



  • FAST TEST


More information

News about Longsee Biomedical


------ 2020


  • January 2020. The "Southwest Chongqing Kaize Longsee Base" was established.
  • In February 2020, South China was the first to respond to the national company against the epidemic and was recognized as a “national material strategic company against the Covid 19 epidemic”.
  • In March 2020, many products got FDA and CE clearance certification, and passed ISO13485 quality management system certification.
  • In April 2020, the “Yiyuan Lanxin subsidiary” was established, focused on the field of consumer goods.
  • In May 2020, it was recognized as "Guangdong Province Human Microecological Engineering Technology Research Center".
  • In June 2020, the South China Base signed a contract to enter the Science and Technology Industrial Park.

------ 2019


  • In May 2019, the subsidiary “Longsee Zhicheng” was established, focused on the field of flora transplantation.
  • In September 2019 the "Beijing Keli Dandi Base" is established
  • November Central China-Wuhan Longsee Base Establishe.

------ 2018


  • In January 2018, Guangzhou McKay subsidiary was established to enter the scientific research services market.
  • Selected as "Government Unit of Guangdong Provincial Health Association" in March 2018
  • In October, the micro-ecological products of the McKay Micro and Dachang bacteria series were launched.
  • In November 2018, the company was named "High-Tech Enterprise"
  • In December 2018, the "Guangzhou Longsee Medical Laboratory" was established
  • In November 2018, the company was named "High-Tech Enterprise"
  • In December 2018, the "Guangzhou Longsee Medical Laboratory" was established

------ 2017


  • Awarded the title of "Platform for creating crowds and foundation for innovation and entrepreneurship" in May 2017.
  • Funding round prior to November A
  • In December 2017, the product was recognized as "Guangdong Province High-tech Product".

------ 2016


  • The first kit was launched in March 2016
  • In May 2016, the R&D Center was formally established
  • In July 2016, it created the Longsee human body microecology data base platform


The Longsee and AACCDI Business Department covers the entire country, integrating regional resources for superior scientific and technological research and development.


An excellent team of talents, fully serve regional economic construction and development, and empower the regulation of healthy human micro-ecological balance. Let human beings be healthier, happier and live longer thanks to the micro-ecological balance!



  • Agreements with 17 associated national hospitals and colleges.

  • More than 350,000 people in service

  • Agreements with 27 associated international schools

  • A total of 16 subsidiaries in permanent development in R&D, and management of Technical-commercial coordination within the territory of Asia, America, Europe and Africa.



Share by: